Optimizing the Alcyone Trial: Efficacy of Daratumumab And Bortezomib Maintenance in Non-Transplant Eligible Newly Diagnosed Multiple Myeloma Patients Post Dara-Vmp Induction, 1 Year Analysis

被引：0

作者：

Tamariz-Amador, Luis Esteban ^{[1
]}

Puertas, Borja ^{[2
]}

Hernandez, Miguel ^{[3
]}

Garcia, Alfonso ^{[4
]}

Jesus Blanchard, Maria ^{[5
]}

Ramirez-Payer, Angel ^{[6
]}

Lerma, Ana ^{[7
]}

Escalante, Fernando ^{[8
]}

Cobo-Rodriguez, Maria Teresa ^{[9
]}

Barez-Garcia, Abelardo ^{[10
]}

Gonzalez-Perez, Marta ^{[11
]}

De Soto, Teresa ^{[12
]}

Suarez-Cabrera, Alexia ^{[13
]}

Martinez-Castro, Margarita ^{[14
]}

Sancho Val, Luis Ignacio ^{[15
]}

Dios Loureiro, Ana ^{[16
]}

Yus Cebrian, Flor ^{[17
]}

Anguita, Magdalena ^{[18
]}

Alonso, Arancha ^{[19
]}

Gimenez Mesa, Eugenio ^{[20
]}

Angel Mendez, Jose ^{[21
]}

Jose Lahuerta, Juan ^{[22
]}

Blade, Joan ^{[23
]}

San-Miguel, Jesus ^{[24
]}

Mateos Manteca, Maria-Victoria ^{[25
]}

机构：

[1] Clin Univ Navarra, IDISNA, Dept Hematol, Pamplona, Spain

[2] Univ Hosp Salamanca, Hematol, Salamanca, Spain

[3] Hosp Univ Canarias, San Cristobal la Laguna, Spain

[4] Hosp Clin Univ Valladolid, Valladolid, Spain

[5] Hosp Univ Ramon & Cajal, Madrid, Spain

[6] Hosp Univ Cent Asturias, Oviedo, Spain

[7] Hosp Univ Gen Nuestra Senora Prado, Talavera De La Reina, Spain

[8] Hosp Univ Leon, Leon, Spain

[9] Hosp Univ Sureste, Madrid, Spain

[10] Complejo Asistencial Avila, Avila, Portugal

[11] Hosp Clin Univ Santiago, Santiago, Chile

[12] Hosp Univ La Paz, La Paz, Mexico

[13] Hosp Univ Gran Canaria Doctor Negrin, Las Palmas Gran Canaria, Spain

[14] Complejo Hosp Univ Vigo, Vigo, Spain

[15] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain

[16] Complejo Hosp Univ Pontevedra, Pontevedra, Spain

[17] Hosp Univ San Jorge, Zaragoza, Spain

[18] Complejo Hosp Jaen, Jaen, Spain

[19] Hosp Univ Ruber Juan Bravo, Madrid, Spain

[20] Hosp Univ Infanta Sofia, Sofia, Bulgaria

[21] Complejo Hosp Univ Orense, Orense, Spain

[22] Hosp Univ 12 Octubre, Madrid, Spain

[23] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp Clin Barcelona, Barcelona, Spain

[24] Clin Univ Navarra, Navarra, Spain

[25] Univ Hosp Salamanca, Inst Biomed Res Salamanca IBSAL, CIBERONC, Salamanca, Spain

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-369

引用

页码：S246 / S247

页数：2

共 50 条

[31] Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Overall Survival in Alcyone
Mateos, Maria-Victoria
Cavo, Michele
Blade, Joan
Dimopoulos, Meletios A.
Suzuki, Kenshi
Jakubowiak, Andrzej
Knop, Stefan
Doyen, Chantal
Lucio, Paulo
Nagy, Zsolt
Pour, Ludek
Cook, Mark
Grosicki, Sebastian
Crepaldi, Andre H.
Liberati, Anna Marina
Campbell, Philip
Shelekhova, Tatiana
Yoon, Sung-Soo
Iosava, Genadi
Fujisaki, Tomoaki
Garg, Mamta
Krevvata, Maria
Wang, Jianping
Kudva, Anupa
Ukropec, Jon
Wroblewski, Susan
Kobos, Rachel
San-Miguel, Jesus
BLOOD, 2019, 134
[32] Induction Therapy with Bortezomib-Cyclophosphamide-Dexamethasone (BCD) for Newly Diagnosed Transplant Eligible Patients with Multiple Myeloma
Tsukada, Nobuhiro
Ikeda, Masahiro
Shingaki, Sumito
Miyazaki, Kanji
Meshitsuka, Sosuke
Abe, Yu
Yoshiki, Yumiko
Suzuki, Kenshi
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S205 - S205
[33] Treatment Sequencing and Efficacy in Newly Diagnosed Non-Transplant Eligible Myeloma Patients in the Netherlands: A Population Based Study
Verelst, S. G. R.
van Norden, Y.
Blommestein, H. M.
Roobol, J.
Schoenmaker, M.
Sonneveld, P.
BLOOD, 2012, 120 (21)
[34] Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE
Mateos, Maria-Victoria
Dimopoulos, Meletios A.
Cavo, Michele
Suzuki, Kenshi
Knop, Stefan
Doyen, Chantal
Lucio, Paulo
Nagy, Zsolt
Pour, Ludek
Grosicki, Sebastian
Crepaldi, Andre
Liberati, Anna Marina
Campbell, Philip
Yoon, Sung-Soo
Iosava, Genadi
Fujisaki, Tomoaki
Garg, Mamta
Iida, Shinsuke
Blade, Joan
Ukropec, Jon
Pei, Huiling
Van Rampelbergh, Rian
Kudva, Anupa
Qi, Ming
San-Miguel, Jesus
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (11): : 785 - 798
[35] Bortezomib, lenalidomide, and dexamethasone (VRd) daratumumab (DARA) in patients (pts) with transplant -eligible (TE) newly diagnosed multiple myeloma (NDMM): A multicenter, randomized, phase Ill study (PERSEUS).
Sonneveld, Pieter
Broijl, Annemiek
Gay, Francesca
Boccadoro, Mario
Einsele, Hermann
Blade, Joan
Dimopoulos, Meletios A.
Delforge, Michel
Spencer, Andrew
Hajek, Roman
Schjesvold, Fredrik
Lonergan, Sarah
Smith, Elena
Carson, Robin L.
Crist, Wendy
Garvin, Wendy S.
Vermeulen, Jessica
Moreau, Philippe
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[36] Daratumumab (DARA) plus Bortezomib/ Thalidomide/Dexamethasone (D-VTd) Followed by DARA Maintenance in Transplant-eligible (TE) Newly Diagnosed Multiple Myeloma (NDMM): >6-Year Update of the Phase 3 CASSIOPEIA Study
Moreau, Philippe
Hulin, Cyrille
Perrot, Aurore
Arnulf, Bertrand
Belhadj, Karim
Benboubker, Lotfi
Zweegman, Sonja
Caillon, Helene
Caillot, Denis
Avet-Loiseau, Herve
Delforge, Michel
Dejoie, Thomas
Facon, Thierry
Sonntag, Cecile
Fontan, Jean
Mohty, Mohamad
Jie, Kon-Siong
Karlin, Lionel
Kuhnowski, Frederique
Lambert, Jerome
Leleu, Xavier
Macro, Margaret
Orsini-Piocelle, Frederique
Roussel, Murielle
de Colella, Jean Marc Schiano
van de Donk, Niels W. C. J.
Wuilleme, Soraya
Broijl, Annemiek
Touzeau, Cyrille
Tiab, Mourad
Marolleau, Jean-Pierre
Meuleman, Nathalie
Vekemans, Marie-Christiane
Westerman, Matthijs
Klein, Saskia K.
Levin, Mark-David
Offner, Fritz
Escoffre-Barbe, Martine
Eveillard, Jean-Richard
Garidi, Reda
Hua, Winnie
Wang, Jianping
Tuozzo, Alba
de Boer, Carla J.
Rowe, Melissa
Vanquickelberghe, Veronique
Carson, Robin
Vermeulen, Jessica
Corre, Jill
Sonneveld, Pieter
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S560 - S561
[37] Daratumumab (Dara), Cyclophosphamide, Thalidomide and Dexamethasone for Transplant Eligible Newly Diagnosed Multiple Myeloma (TE NDMM) Patients: Response Rate Impacts on PFS
Crusoe, Edvan De Queiroz
Leal, Joanna
Santos, Juliana Andrade
de Melo Santos, Herbert Henrique
Santos, Allan de Souza
Lucas, Larissa Ferreira
Almeida, Alessandro de M.
Chaves, Marcos
Dutra, Daniela Dourado
Hungria, Vania T. M.
Salvino, Marco Aurelio
Arruda, Maria da Gloria B.
BLOOD, 2022, 140 : 7699 - 7700
[38] Real-World Data on the Daratumumab Plus Bortezomib, Thalidomide and Dexamethasone Followed by Lenalidomide Maintenance for Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients
Crusoe, Edvan de Queiroz
Ribeiro, Glaciano
Moura, Fernanda
Costa, Abel
Aranha, Milton
Bittencourt, Rosane
Ribeiro, Eduardo
Neto, Jorge
Cunha, Rafael
Mattos, Ederson
Braga, Walter
Lima, Juliana Souza
Gusmao, Breno
Lopes, Danielle Ovigli
Berg, Luiza
Souto, Joao
Maiolino, Angelo
Hungria, Vania T. M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S223 - S223
[39] Successful MPB Therapy Followed By Bortezomib Maintenance for Non-Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma: Japanese Phase 2 Study - Broad-J Study
Tokuhira, Michihide
Takezako, Naoki
Imai, Yoichi
Ishida, Tadao
Nakazato, Tomonori
Mitani, Kinuko
Ikuta, Tohru
Matsumoto, Morio
Ikezoe, Takayuki
Taguchi, Jun
Usuki, Kensuke
Shimomura, Takeshi
Chin, Kenkou
Arai, Shunya
Ohyashiki, Kazuma
Nara, Miho
Kishi, Kenji
Kuroda, Yoshiaki
Nakamura, Yuichi
Wakita, Hisashi
Sasaki, Makoto
Kamata, Hirotoshi
Ichikawa, Yoshikazu
Yokoyama, Akihiko
Suzuki, Kenshi
Kizaki, Masahiro
BLOOD, 2017, 130
[40] Impact of Daratumumab (DARA) administration during transplant-eligible newly diagnosed Multiple Myeloma (TE NDMM) induction on stem cell (SC) mobilization count and post-transplant engraftment
Crusoe, Edvan
Almeida, Alessandro
Chaves, Marcos
Salvino, Marco
Nicanor, Jamile
Leal, JOanna
Santos, Herbert
Santos, Allan
Guimaraes, Victor
Dourado, Daniela
Lucas, Larissa
Santos, Mariane
Santos, Juliana
Arruda, Maria da Gloria
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S131 - S131

← 1 2 3 4 5 →